Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Banchereau

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Immunological Reviews|July 11, 2008
How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targetsVirginia Pascual, Florence Allantaz, Pinakeen Patel, et al.
Mobile DNA|February 22, 2025
Alternative splicing of transposable elements in human breast cancerAlex Nesta, Diogo F T Veiga, Jacques Banchereau, et al.
Seminars in Immunology|September 17, 2023
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BISDjamel Nehar-Belaid, Mark Sokolowski, Sathyabaarathi Ravichandran, et al.
Journal of Clinical Immunology|December 29, 2005
Human dendritic cell subsets for vaccinationPeter Dubsky, Hideki Ueno, Bernard Piqueras, et al.
European Journal of Immunology|August 9, 2007
Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTLTinghua Cao, Hideki Ueno, Casey Glaser, et al.
Immunity|August 23, 2003
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6Gaetan Jego, A Karolina Palucka, Jean-Philippe Blanck, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanomaA Karolina Palucka, Madhav V Dhodapkar, Sophie Paczesny, et al.
Human Immunology|December 14, 2002
Blood dendritic cells and DC-poietins in systemic lupus erythematosusMichelle A Gill, Patrick Blanco, Edsel Arce, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
The Journal of Experimental Medicine|June 3, 2004
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cellsSophie Paczesny, Jacques Banchereau, Knut M Wittkowski, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Immunological Reviews|July 11, 2008
How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targetsVirginia Pascual, Florence Allantaz, Pinakeen Patel, et al.
Mobile DNA|February 22, 2025
Alternative splicing of transposable elements in human breast cancerAlex Nesta, Diogo F T Veiga, Jacques Banchereau, et al.
Seminars in Immunology|September 17, 2023
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BISDjamel Nehar-Belaid, Mark Sokolowski, Sathyabaarathi Ravichandran, et al.
Journal of Clinical Immunology|December 29, 2005
Human dendritic cell subsets for vaccinationPeter Dubsky, Hideki Ueno, Bernard Piqueras, et al.
European Journal of Immunology|August 9, 2007
Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTLTinghua Cao, Hideki Ueno, Casey Glaser, et al.
Immunity|August 23, 2003
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6Gaetan Jego, A Karolina Palucka, Jean-Philippe Blanck, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanomaA Karolina Palucka, Madhav V Dhodapkar, Sophie Paczesny, et al.
Human Immunology|December 14, 2002
Blood dendritic cells and DC-poietins in systemic lupus erythematosusMichelle A Gill, Patrick Blanco, Edsel Arce, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
The Journal of Experimental Medicine|June 3, 2004
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cellsSophie Paczesny, Jacques Banchereau, Knut M Wittkowski, et al.
Pageof 22